Circulation Research, Vol 73, 869-886, Copyright © 1993 by American Heart Association

ARTICLES

Impact of alpha-adrenergic coronary vasoconstriction on the transmural myocardial blood flow distribution during humoral and neuronal adrenergic activation

D Baumgart, T Ehring, P Kowallik, BD Guth, M Krajcar and G Heusch
Department of Pathophysiology, University of Essen Medical School, FRG.

Increased heart rate and left ventricular pressure during humoral and neuronal adrenergic activation act to restrict blood flow preferentially in the subendocardium. The hypothesis was advanced that alpha-adrenergic coronary vasoconstriction preferentially in the subepicardium may counterbalance the enhanced extravascular compression in the subendocardium and serve to maintain blood flow transmurally uniform. In 40 anesthetized dogs, regional myocardial blood flow was determined with colored microspheres; wall function, with sonomicrometry. Humoral adrenergic activation (HAA) was induced by a combination of intravenous atropine, intravenous norepinephrine, and atrial pacing during baseline coronary vasomotor tone (group 1, n = 6) and in the presence of maximal coronary vasodilation with intravenous dipyridamole (group 2, n = 6). In an additional group, HAA was induced by intravenous norepinephrine in the presence of dipyridamole but without atropine and atrial pacing in order to increase end-diastolic left ventricular pressure (group 3, n = 6). Measurements were performed at rest, during HAA, and during ongoing HAA with the intracoronary infusion of the alpha-antagonist phentolamine (Phen). At unchanged mean aortic pressure, Phen improved blood flow particularly to the inner layers as follows: from 1.42 +/- 0.40 (mean +/- SD) to 1.90 +/- 0.40 mL/(min.g) (group 1, P < .05), from 4.99 +/- 2.31 to 5.53 +/- 2.56 mL/(min.g) (group 2, P < .05), and from 6.01 +/- 1.41 to 6.29 +/- 1.27 mL/(min.g) (group 3, P < .05), associated with a decrease in outer layer blood flow in groups 2 and 3. In 16 additional dogs, beta- adrenoceptors were blocked by propranolol and muscarinic receptors by atropine. Neuronal adrenergic activation (NAA) was induced by cardiac sympathetic nerve stimulation (CSNS) during baseline coronary vasomotor tone (group 4, n = 8) and in the presence of maximal vasodilation (group 5, n = 8). Measurements were performed at rest, during a first CSNS, and 20 minutes later during a second CSNS+Phen. The reproducibility of two consecutive episodes of CSNS 20 minutes apart was demonstrated in a separate set of experiments (n = 6). At matched mean aortic pressures, Phen improved blood flow to all myocardial layers in group 4, whereas in group 5, Phen induced a redistribution of myocardial blood flow toward subepicardial layers [from 4.44 +/- 0.96 to 4.81 +/- 0.83 mL/(min.g), P < .05] at the expense of inner layers. With the addition of Phen, there was no change in regional wall function in any group of dogs studied. Thus, during HAA, alpha- adrenergic coronary vasoconstriction does not exert a beneficial effect on transmural blood flow distribution. During NAA, a beneficial effect of alpha-adrenergic coronary vasoconstriction becomes apparent only under conditions of maximal coronary vasodilation.

This article has been cited by other articles:

				E. Barbato Role of adrenergic receptors in human coronary vasomotion Heart, April 1, 2009; 95(7): 603 - 608. [Full Text] [PDF]

				A. Momen, V. Mascarenhas, A. Gahremanpour, Z. Gao, R. Moradkhan, A. Kunselman, J. P. Boehmer, L. I. Sinoway, and U. A. Leuenberger Coronary blood flow responses to physiological stress in humans Am J Physiol Heart Circ Physiol, March 1, 2009; 296(3): H854 - H861. [Abstract] [Full Text] [PDF]

				D. J. Duncker and R. J. Bache Regulation of Coronary Blood Flow During Exercise Physiol Rev, July 1, 2008; 88(3): 1009 - 1086. [Abstract] [Full Text] [PDF]

				P. Zong, J. D. Tune, and H. F. Downey Mechanisms of Oxygen Demand/Supply Balance in the Right Ventricle Experimental Biology and Medicine, September 1, 2005; 230(8): 507 - 519. [Abstract] [Full Text] [PDF]

				G. Sambuceti, M. Marzilli, A. Mari, C. Marini, M. Schluter, R. Testa, M. Papini, P. Marraccini, G. Ciriello, P. Marzullo, et al. Coronary microcirculatory vasoconstriction is heterogeneously distributed in acutely ischemic myocardium Am J Physiol Heart Circ Physiol, May 1, 2005; 288(5): H2298 - H2305. [Abstract] [Full Text] [PDF]

				O. Manfrini, G. Morgagni, C. Pizzi, F. Fontana, and R. Bugiardini Changes in autonomic nervous system activity: spontaneous versus balloon-induced myocardial ischaemia Eur. Heart J., September 1, 2004; 25(17): 1502 - 1508. [Abstract] [Full Text] [PDF]

				S. Setty, W. Sun, R. Martinez, H. F. Downey, and J. D. Tune {alpha}-Adrenoceptor-mediated coronary vasoconstriction is augmented during exercise in experimental diabetes mellitus J Appl Physiol, July 1, 2004; 97(1): 431 - 438. [Abstract] [Full Text] [PDF]

				P. Zong, W. Sun, S. Setty, J. D. Tune, and H. F. Downey {alpha}-Adrenergic Vasoconstrictor Tone Limits Right Coronary Blood Flow in Exercising Dogs Experimental Biology and Medicine, April 1, 2004; 229(4): 312 - 322. [Abstract] [Full Text] [PDF]

				G. Heusch, D. Baumgart, P. Camici, W. Chilian, L. Gregorini, O. Hess, C. Indolfi, and O. Rimoldi {alpha}-Adrenergic Coronary Vasoconstriction and Myocardial Ischemia in Humans Circulation, February 15, 2000; 101(6): 689 - 694. [Abstract] [Full Text] [PDF]

				D. Baumgart, M. Haude, G. Gorge, F. Liu, J. Ge, C. Große-Eggebrecht, R. Erbel, and G. Heusch Augmented {{alpha}}-Adrenergic Constriction of Atherosclerotic Human Coronary Arteries Circulation, April 27, 1999; 99(16): 2090 - 2097. [Abstract] [Full Text] [PDF]

				K. Morita, H. Mori, K. Tsujioka, A. Kimura, Y. Ogasawara, M. Goto, O. Hiramatsu, F. Kajiya, and E. O. Feigl alpha -Adrenergic vasoconstriction reduces systolic retrograde coronary blood flow Am J Physiol Heart Circ Physiol, December 1, 1997; 273(6): H2746 - H2755. [Abstract] [Full Text] [PDF]